Published in Clin Exp Gastroenterol on August 03, 2016
Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease. Heart Fail Clin (2017) 0.75
Celiac disease. N Engl J Med (2007) 10.98
Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet (2011) 6.36
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. N Engl J Med (2012) 5.80
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet (2001) 5.56
The prevalence of celiac disease in the United States. Am J Gastroenterol (2012) 4.77
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet (2003) 3.78
Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc (2012) 3.60
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut (2003) 3.30
Celiac disease: from pathogenesis to novel therapies. Gastroenterology (2009) 2.84
Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol (2000) 2.55
Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology (2008) 2.39
Optimising delivery of care in coeliac disease - comparison of the benefits of repeat biopsy and serological follow-up. Aliment Pharmacol Ther (2013) 2.18
Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease. Aliment Pharmacol Ther (2014) 2.10
Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol (2006) 2.04
The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol (2011) 1.96
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut (2007) 1.92
Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol (2010) 1.88
Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol (2007) 1.82
Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol (2002) 1.81
Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol (2002) 1.79
Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr (2012) 1.73
Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther (2009) 1.72
Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology (1998) 1.71
Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma. N Engl J Med (2006) 1.69
Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology (2008) 1.63
Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol (2008) 1.53
Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut (2012) 1.52
Classification and management of refractory coeliac disease. Gut (2010) 1.48
Tioguanine in the treatment of refractory coeliac disease--a single centre experience. Aliment Pharmacol Ther (2012) 1.48
Changing presentation of adult celiac disease. Dig Dis Sci (2003) 1.44
Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol (2006) 1.37
Celiac disease: how complicated can it get? Immunogenetics (2010) 1.34
Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment Pharmacol Ther (2007) 1.33
Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood (2006) 1.31
Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc Natl Acad Sci U S A (2009) 1.28
IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest (2010) 1.28
Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther (2003) 1.28
Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology (2002) 1.26
Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease. Clin Immunol (2007) 1.26
Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol (2007) 1.23
Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology (2000) 1.22
Refractory coeliac disease: remission with infliximab and immunomodulators. Eur J Gastroenterol Hepatol (2005) 1.15
Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Ann Intern Med (2013) 1.11
Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? Aliment Pharmacol Ther (2007) 1.10
Commentary: refractory coeliac disease - rigorous management revealing, or resulting in, rarity? Aliment Pharmacol Ther (2014) 1.08
Celiac disease: management of persistent symptoms in patients on a gluten-free diet. World J Gastroenterol (2012) 1.07
Long-term histological follow-up of people with coeliac disease in a UK teaching hospital. QJM (2010) 1.06
Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study. Aliment Pharmacol Ther (2000) 1.05
Evaluation of Cladribine treatment in refractory celiac disease type II. World J Gastroenterol (2011) 1.04
Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship. Hum Pathol (1989) 1.04
The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol (2015) 1.03
MR enteroclysis in refractory celiac disease: proposal and validation of a severity scoring system. Radiology (2011) 1.00
Studies on the effects of cortisone and pituitary adrenocorticotropic hormone (ACTH) in the sprue syndrome. Gastroenterology (1951) 1.00
18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med (2006) 0.99
Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol (2002) 0.99
Therapy with budesonide in patients with refractory sprue. Digestion (2006) 0.98
A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease. Eur J Gastroenterol Hepatol (2001) 0.98
Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol (2002) 0.98
Presentation of celiac disease. Gastrointest Endosc Clin N Am (2012) 0.98
Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study. Gut (2015) 0.97
Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology (2003) 0.96
A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules. Aliment Pharmacol Ther (2003) 0.96
Clinical characteristics and long-term outcome of patients with refractory sprue diagnosed at a single institution. Acta Gastroenterol Latinoam (2006) 0.96
Diagnosis and treatment of celiac disease. Mucosal Immunol (2008) 0.96
Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy. Bone Marrow Transplant (2010) 0.95
Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Dig Liver Dis (2007) 0.93
Gut delivery of budesonide, a locally active corticosteroid, from plain and controlled-release capsules. Eur J Gastroenterol Hepatol (2002) 0.90
Is refractory celiac disease more severe in old Europe? Am J Gastroenterol (2011) 0.89
Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management. World J Gastroenterol (2013) 0.88
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients. Clin Sci (Lond) (2014) 0.87
Late effects after autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant (2009) 0.87
Treatment response in enteropathy associated T-cell lymphoma; survival in a large multicenter cohort. Am J Hematol (2015) 0.86
A child with refractory coeliac disease. J Pediatr Gastroenterol Nutr (2011) 0.85
Infliximab in refractory coeliac disease. Eur J Gastroenterol Hepatol (2005) 0.85
Identical T-cell receptor beta chain rearrangements are present in T cells infiltrating the jejunal mucosa of untreated celiac patients. Hum Immunol (1997) 0.84
Flow cytometry of intestinal intraepithelial lymphocytes in celiac disease. J Immunol Methods (2010) 0.83
TNF-alpha antibody treatment in refractory collagenous sprue: report of a case and review of the literature. Z Gastroenterol (2009) 0.83
Elemental diet in the treatment of refractory coeliac disease. Eur J Gastroenterol Hepatol (2001) 0.83
The management of refractory coeliac disease. Ther Adv Chronic Dis (2013) 0.83
Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease. Clin Gastroenterol Hepatol (2005) 0.83
Predictors and Significance of Incomplete Mucosal Recovery in Celiac Disease After 1 Year on a Gluten-Free Diet. Am J Gastroenterol (2015) 0.82
Anti-calreticulin immunoglobulin A (IgA) antibodies in refractory coeliac disease. Clin Exp Immunol (2008) 0.82
Video capsule endoscopy in celiac disease: current clinical practice. J Dig Dis (2012) 0.82
The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease. Gut (2015) 0.81
Mechanisms and management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol (2015) 0.80
Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience. Nutrients (2015) 0.79
Is TCRgamma clonality assay useful to detect early celiac disease? J Clin Gastroenterol (2007) 0.78
Therapy in RCDII: Rationale for Combination Strategies? Dig Dis (2015) 0.78
Treatment failure in coeliac disease: a practical guide to investigation and treatment of non-responsive and refractory coeliac disease. J Gastrointestin Liver Dis (2012) 0.78
Weaknesses of histological analysis in celiac disease diagnosis: new possible scenarios. Scand J Gastroenterol (2014) 0.76